Small Lung Tumours: High Risk Lesions and Contraindications to Stereotactic Ablative Body Radiotherapy (SABR)

被引：0
|
作者：
Ball, D. [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Radiat Oncol, Melbourne, Vic, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Stereotactic ablative radiotherapy; contraindications;
D O I：
10.1016/j.jtho.2018.08.080
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MTE24.02
引用
收藏
页码：S225 / S226
页数：2
相关论文
共 50 条
  • [1] Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours
    Goldsmith, Christy
    Gaya, Andrew
    CANCER IMAGING, 2012, 12 (02): : 351 - 360
  • [2] Stereotactic ablative body radiotherapy (SABR) for multiple lung tumours: hazardous or harmless?
    Allos, B.
    Carruthers, H.
    Harrop, V.
    Stange, D.
    Misheva, T.
    Stevenson, R.
    Watkins, S.
    Ghafoor, Q.
    LUNG CANCER, 2018, 115 : S58 - S58
  • [3] A national program for the implementation of lung Stereotactic Ablative Body Radiotherapy (SABR)
    Diez, P.
    Haridass, A.
    Lilley, J.
    Patel, R.
    Miles, E.
    Tree, A.
    Clark, C.
    Dean, C.
    Fell, K.
    McDonald, F.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S868 - S870
  • [4] Our experience in treating lung tumours using stereotactic ablative body radiotherapy (SABR) at Northampton General Hospital
    Yusof, H.
    Gore, A.
    Mak, C. I.
    Eldeeb, H.
    Vaidya, D.
    Acquah, H.
    Whilde, N.
    LUNG CANCER, 2015, 87 : S46 - S46
  • [5] STEREOTACTIC ABLATIVE BODY RADIOTHERAPY (SABR) OUTCOMES FOR PRIMARY AND METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) PULMONARY TUMOURS
    Thibault, Isabelle
    Poon, Ian
    Erler, Darby
    Kim, Anthony
    Keller, Brian
    Yeung, Latifa
    Jain, Suneil
    Soliman, Hany
    Lochray, Fiona
    Cheung, Patrick
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S837 - S838
  • [6] Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer
    Desai, Neil B.
    Laine, Aaron M.
    Timmerman, Robert D.
    BRITISH JOURNAL OF RADIOLOGY, 2017, 90 (1070):
  • [7] A case for development of stereotactic ablative body radiotherapy (SABR) for lung cancer at Aberdeen
    Stilwell, C.
    Steven, E.
    Sharma, R. N.
    Bissett, D.
    Shrimali, R. K.
    LUNG CANCER, 2013, 79 : S58 - S59
  • [8] To SABR or Not to SABR? Indications and Contraindications for Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage, Oligometastatic, or Oligoprogressive Non-Small Cell Lung Cancer
    Shultz, David Benjamin
    Diehn, Maximilian
    Loo, Billy W., Jr.
    SEMINARS IN RADIATION ONCOLOGY, 2015, 25 (02) : 78 - 86
  • [9] Stereotactic Ablative Radiotherapy (SABR) for Non-Small Cell Lung Cancer
    Iyengar, Puneeth
    Westover, Kenneth
    Timmerman, Robert D.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (06) : 845 - 854
  • [10] SMALL BOWEL TOLERANCE IN STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR)
    Faria, Sergio
    Kopek, Neil
    Ashram, Samaher
    Patrocinio, Horacio
    RADIOTHERAPY AND ONCOLOGY, 2019, 139 : S97 - S97
12345